Mirabegron
ATC G04BD12 · 10 markets · 89 records
CN 33 records · 2 strengths
US 21 records · 4 strengths
GB 9 records · 2 strengths
- 50 mgtablet · extended-releaseBetmiga 50mg modified-release tablets__no_trade__
- 25 mgtablet · extended-releaseBetmiga 50mg modified-release tablets__no_trade__
CA 6 records · 2 strengths
- 50 mgtablet · extended-releaseAPO-MIRABEGRONAURO-MIRABEGRON、Myrbetriq、SANDOZ MIRABEGRON
- 25 mgtablet · extended-releaseAPO-MIRABEGRONMyrbetriq
AU 3 records · 3 strengths
- 50 mgtablet · extended-releaseBETMIGA mirabegron 25 mg film-coated prolonged-release tablet blister pack
- 25 mgtablet · extended-releaseBETMIGA mirabegron 25 mg film-coated prolonged-release tablet blister pack
Records without a stated strength · 1 BETMIGA
TW 3 records · 2 strengths
- 50 mgtablet · extended-releaseBetmiga Prolonged-release Tablets 50mgMiralin Prolonged-release Tablets 50mg、泌立寧持續性藥效錠50毫克、貝坦利持續性藥效錠50毫克
- 25 mgtablet · extended-releaseBetmiga Prolonged-release Tablets 50mg貝坦利持續性藥效錠25毫克
SG 2 records · 2 strengths
- 50 mgtablet · extended-releaseBetmiga Prolonged-release Tablets 50mg
- 25 mgtablet · extended-releaseBetmiga Prolonged-release Tablets 50mg
HK 2 records · 1 strengths
Records without a stated strength · 1 Betmiga Prolonged-release Tablets 50mg
ES 1 records · 1 strengths
- 50 mgtablet · extended-releaseBETMIGA
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 BETMIGA
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 50 mg tablet · extended-release | No trade name Mirabgeorn Myrbetriq | No trade name Betmiga 50mg modified-release tablets | APO-MIRABEGRON AURO-MIRABEGRON Myrbetriq+1SANDOZ MIRABEGRON | BETMIGA mirabegron 25 mg film-coated prolonged-release tablet blister pack | Betmiga Prolonged-release Tablets 50mg | Manufacturer: 华润赛科药业有限责任公司 Manufacturer: 南京正大天晴制药有限公司 ×4 Manufacturer: 四川国为制药有限公司 ×3+7Manufacturer: 江苏华鑫制药有限公司 ×3 Manufacturer: 江苏德源药业股份有限公司 ×3 Manufacturer: 江西山香药业有限公司 ×3 Manufacturer: 浙江华义制药有限公司 ×4 Manufacturer: 石药集团中诺药业(石家庄)有限公司 ×4 Manufacturer: 齐鲁制药有限公司 贝坦利米拉贝隆 | BETMIGA | Betmiga Prolonged-release Tablets 50mg Miralin Prolonged-release Tablets 50mg 泌立寧持續性藥效錠50毫克 | ||
| 25 mg tablet · extended-release | No trade name Myrbetriq | No trade name Betmiga 50mg modified-release tablets | APO-MIRABEGRON Myrbetriq | BETMIGA mirabegron 25 mg film-coated prolonged-release tablet blister pack | Betmiga Prolonged-release Tablets 50mg | Manufacturer: 深圳万乐药业有限公司 ×2 贝坦利米拉贝隆 | Betmiga Prolonged-release Tablets 50mg 貝坦利持續性藥效錠25毫克 | |||
| 8 mg liquid · extended-release | No trade name | |||||||||
| 8 mg powder · extended-release | Myrbetriq | |||||||||
unknown | BETMIGA | Betmiga Prolonged-release Tablets 50mg | BETMIGA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in AU · HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en AU · HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 AU · HK · EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 AU · HK · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.